Propranolol
Buy now to access the full article, existing subscribers login
Class of drug
- Beta-1 and beta-2 adrenoceptor antagonist.
Uses
Action
- A beta-adrenoceptor antagonist. It antagonizes beta-1 adrenoceptors, blocking their chronotropic and inotropic effects on the heart, and beta-2 adreoceptors, blocking their vasodilatory actions.
- Highly lipid-soluble and crosses into the central nervous system (CNS). It is rapidly metabolized by the liver (high first-pass effect).
- An effective antihypertensive drug in humans, acting through reducing cardiac output, altering the baroreceptor reflex sensitivity and blocking peripheral adrenoceptors.
Indications
- Management of cardiac arrhythmias
(sinus tachycardia, atrial fibrillation or flutter, supraventricular tachycardia, premature ventricular depolarization), hypertrophic cardiomyopathy or obstructive heart disease.
- Control of the cardiac features of thyrotoxicosis prior to surgery in patients with hyperthyroidism
.
- May be used to control the pulse rate in patients with phaeochromocytoma
; always use with phenoxybenzamine
for this indication, as beta-blockade without concurrent alpha-blockade may lead to a hypertensive crisis.
Adverse reactions
Other reported reactions
- Bradycardia.
- Impaired AV conduction.
- Myocardial depression.
- Heart failure.
- Syncope.
- Glucose intolerance.
- Bronchospasm.
- Diarrhea.
- Peripheral vasoconstriction.
- Depression and lethargy (the result of propranolol's high lipid-solubility and its penetration into the CNS).
- May reduce glomerular filtration rate and therefore excacerbate any pre-existing renal impairment.
Sample content only, to unlock the full article
login or buy now